Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Payer

China flag thumb

Pharma nervous as China probes drug prices

Local affiliates of multinationals and domestic companies in the spot light

- PMLiVE

Biotechs urged to focus on value

Simply creating a drug that works may not be enough warns new report

- PMLiVE

Pharma bites back against Obama’s healthcare proposals

Call to cut Medicare payments for prescription drugs

- PMLiVE

GSK sales drop as austerity measures hit business in Europe

Revenues in region drop 9 per cent

Market access opportunities in China

Pope Woodhead highlights the key steps to accessing the high-value therapeutics market in China

- PMLiVE

Ireland forges drug pricing pact with pharma

Could cut drug bill by €400m

EC pricing and reimbursement efficiency plans

The European Commission (EC) is working to help medicines reach the market quicker by streamlining the pricing and reimbursement process

China flag thumb

China slashes drug prices as healthcare reforms announced

Raft of measures to cut healthcare costs include 17 per cent price reduction for cancer drugs

- PMLiVE

Demonstrating value and improving access

In today’s dynamic healthcare market, it’s all about how we can demonstrate value and improve access – it is the art of effective communication and education that will enable success

- PMLiVE

Embracing the new paradigm in pharma market access

Pharma needs to change its image from being drug producers to healthcare provider partners

- PMLiVE

The journey to market access 5.0

Few in pharma are unaware of the importance of delivering demonstrable value in collaboration with payers. But are we serious about patient outcomes?

- PMLiVE

Market access webinar series begins with UK healthcare changes

Experts convene for first Sudler & Hennessey and Kantar Health online event

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links